Deloitte Projects $527 Billion U.S. Women's Health Opportunity Through Proactive Care
Event summary
- Deloitte estimates a $527 billion growth opportunity in U.S. women's health by 2030 through proactive, life-stage-aware care.
- Model suggests potential 20-year increase in women's health span with prevention-focused interventions.
- Four key clinical areas—brain health, pelvic health, cardiovascular care, and musculoskeletal/autoimmune conditions—highlight convergence of unmet needs and market demand.
- Analysis based on five years of medical and pharmacy claims data from nearly 60 million lives.
The big picture
Deloitte's analysis underscores the strategic shift from reactive to proactive healthcare, driven by advancements in diagnostics and preventive care. The $527 billion opportunity highlights the potential for improved health outcomes and sustainable market growth, particularly in areas where unmet clinical needs align with emerging technologies. This trend reflects broader industry movements toward personalized and life-stage-aware healthcare solutions.
What we're watching
- Investment Trends
- How investors will allocate capital toward scalable platforms advancing sex-specific diagnostics and treatments.
- Technological Adoption
- The pace at which AI-enabled and continuous monitoring tools are integrated into routine healthcare workflows.
- Regulatory Impact
- Whether health plans and employers will adjust benefit designs to facilitate early preventive screenings and reduce out-of-pocket costs.